<SEC-DOCUMENT>0000950170-25-062018-index.html : 20250501
<SEC-HEADER>0000950170-25-062018.hdr.sgml : 20250501
<ACCEPTANCE-DATETIME>20250501172125
ACCESSION NUMBER:		0000950170-25-062018
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250428
FILED AS OF DATE:		20250501
DATE AS OF CHANGE:		20250501

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Frohlich Tom
		CENTRAL INDEX KEY:			0001823925
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40544
		FILM NUMBER:		25904433

	MAIL ADDRESS:	
		STREET 1:		C/O CHINOOK THERAPEUTICS U.S., INC.
		STREET 2:		1600 FAIRVIEW AVE. E.
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jade Biosciences, Inc.
		CENTRAL INDEX KEY:			0001798749
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				831377888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		221 CRESCENT ST.
		STREET 2:		BUILDING 23, SUITE 105
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		(781) 312-3013

	MAIL ADDRESS:	
		STREET 1:		221 CRESCENT ST.
		STREET 2:		BUILDING 23, SUITE 105
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aerovate Therapeutics, Inc.
		DATE OF NAME CHANGE:	20200103
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>3
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ck0001798749-ex24.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: ck0001798749-ex24.htm

</DOCUMENT>
</SEC-DOCUMENT>